Diagnos Laboratorium Utama Tbk. vs Pelayaran Tamarin Samudra Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B, 27.5K 24h volume), while Pelayaran Tamarin Samudra Tbk. trades at Rp20 (market cap 750B, 894.9K 24h volume). The key difference: Pelayaran Tamarin Samudra Tbk. is far larger — about 2.4× Diagnos Laboratorium Utama Tbk.'s market cap, and Pelayaran Tamarin Samudra Tbk. is more actively traded (894.9K versus 27.5K). Which is the better fit depends on your goals.
| DGNS | TAMU | |
|---|---|---|
Market Cap | 308B | 750B |
Volume | 27.5K | 894.9K |
Lot | 275 | 8.95K |
Turnover | 6.23M | 17.27M |
Average Price | 226.59 | 19.3 |
Value | 6.23M | 17.27M |
Indicative Equilibrium Price | 230 | 20 |
Indicative Equilibrium Volume | 110 | 282 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Pelayaran Tamarin Samudra Tbk (the Company) was established based on the Deed of Notary Linda Ibrahim, SH, No. 38 dated August 27, 1998. The company services are include offshore marine support such as chartering, re-chartering and transshipment services of Accommodation Work Barge (AWB), Anchor Handling Towing Supply (AHTS).
Read more on TAMU →